FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100659 [Registered on: 09/01/2026] Trial Registered Prospectively
Last Modified On: 09/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Early Care Intervention for early newborns 
Scientific Title of Study   Effectiveness of Early Developmental Stimulation Among Late Preterm Infants 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Revathi Ramendran 
Designation  Student 
Affiliation  Saveetha College of Physiotherapy 
Address  Saveetha College of Physiotherapy, AHS 4th floor, Saveetha Institute of Medical and Technical Sciences, Thandalam. Chennai TAMIL NADU 602105 India

Chennai
TAMIL NADU
602105
India 
Phone  7306752675  
Fax    
Email  revathiramendran0@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anees Ahmed FM 
Designation  Lecturer 
Affiliation  Saveetha College of Physiotherapy 
Address  Saveetha College of Physiotherapy, AHS 4th floor, Saveetha Institute of Medical and Technical Sciences, Thandalam. Chennai TAMIL NADU 602105 India

Chennai
TAMIL NADU
602105
India 
Phone  9043965344  
Fax    
Email  fmanees04@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Revathi Ramendran 
Designation  Student 
Affiliation  Saveetha College of Physiotherapy 
Address  Saveetha College of Physiotherapy, AHS 4th floor, Saveetha Institute of Medical and Technical Sciences, Thandalam. Chennai TAMIL NADU 602105 India


TAMIL NADU
602105
India 
Phone  07306752675  
Fax    
Email  revathiramendran0@gmail.com  
 
Source of Monetary or Material Support  
Saveetha College of Physiotherapy, AHS 4th floor, Saveetha Institute of Medical and Technical Sciences, Thandalam, Chennai, India - 602105 
 
Primary Sponsor  
Name  Revathi Rameandran 
Address  Saveetha College of Physiotherapy, AHS 4th floor, Saveetha Institute of Medical and Technical Sciences, Thandalam, Chennai, India - 602105 
Type of Sponsor  Other [Other [Self] ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vignesh Srinivasan  Saveetha Medical College and Hospital   Department of Physiotherapy, 1st Floor, Paediatric Physiotherapy Unit, Thandalam, Chennai 602 105. Chennai TAMIL NADU
Chennai
TAMIL NADU 
8760563032

vignesh.scpt@saveetha.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL SCIENTIFIC REVIEW BOARD  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: P073||Preterm [premature] newborn [other],  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Early Developmental Stimulation (Oromotor Stimulation + Tactile-Kinesthetic Stimulation)  Early Developmental Stimulation will be administered to late preterm infants born between 34 weeks and 36 weeks 6 days of gestation. The intervention will be initiated within the first 7 days of postnatal life, once the infant is medically stable. The protocol consists of two components: oromotor stimulation and tactile-kinesthetic stimulation, provided under NICU safety guidelines by trained neonatal physiotherapists. Oromotor stimulation will be given to infants from 34 to 36 weeks gestational age to enhance sucking ability and oral motor coordination. The intervention includes gentle tactile stimulation of the lips, cheeks, gums, and tongue using a gloved finger to facilitate oral reflexes and improve feeding efficiency. This component will be administered for 5–7 minutes per session, when the infant is calm and alert. Tactile-kinesthetic stimulation will be provided to promote muscle tone, sensory-motor integration, and motor development. This includes gentle tactile input and passive range of motion exercises of the upper and lower limbs with controlled flexion and extension movements. Kinesthetic stimulation will be administered for 10–15 minutes per session. Each intervention session will last approximately 20 minutes, delivered five days per week. The intervention will be continued for a duration of up to six months or until hospital discharge, whichever occurs earlier. Vital signs including heart rate, respiratory rate, and oxygen saturation will be monitored before, during, and after each session. The intervention will be discontinued immediately if signs of physiological instability or distress are observed. 
Comparator Agent  Standard Routine Neonatal Care as per NICU Protocol  Infants allocated to the control group will receive standard routine neonatal care as per the Neonatal Intensive Care Unit (NICU) and postnatal ward protocols of Saveetha Medical College Hospital. This routine care will be provided to late preterm infants born between 34 weeks and 36 weeks 6 days of gestation, starting from birth and continuing throughout the hospital stay. Standard routine care includes regular medical and nursing management such as thermoregulation, monitoring of vital signs, nutritional support (breastfeeding, expressed breast milk, or gavage feeding as advised by the neonatologist), positioning for comfort and safety, infection prevention measures, and routine handling for medical and nursing procedures. No structured oromotor stimulation or tactile-kinesthetic developmental stimulation will be provided as part of the study intervention. All infants in the control group will undergo routine developmental monitoring and follow-up assessments as per hospital policy. Outcome measures, including Hammersmith Infant Neurological Examination (HINE) and Gross Motor Function Measure (GMFM), will be assessed at the same time points as the intervention group to allow comparison between groups. No additional therapeutic stimulation beyond routine neonatal care will be administered. 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  3.00 Month(s)
Gender  Both 
Details  Gestational age at birth between 34 weeks to 36 weeks 6 days (i.e., Late Preterm Infants).
Admitted to NICU or postnatal ward within the study hospital during the data collection period.
Postnatal age: Infants enrolled within first 7 days of life.
comparison between HINE Scoring and GMFM
 
 
ExclusionCriteria 
Details  structural abnormalities
Infants with major congenital anomalies or known genetic syndromes (e.g., Down syndrome, Edward syndrome).
Recent surgeries.
Parents/guardians unwilling or unable to provide informed consent 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
HINE Scoring  Baseline (T0), 4 weeks (T1), 24 weeks (T2) 
 
Secondary Outcome  
Outcome  TimePoints 
GMFM  Baseline (T0), 4 weeks (T1), 24 weeks (T2) 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Late preterm infants born between 34 and 36 weeks of gestation are at higher risk of delayed feeding growth and neurodevelopment due to physiological immaturity. Early developmental stimulation using oromotor and kinesthetic techniques may help improve sucking ability weight gain muscle tone and motor development during early life. This prospective experimental study aims to evaluate the effectiveness of early developmental stimulation among late preterm infants. A total of 50 infants will be selected using convenience sampling and divided into an intervention group receiving early developmental stimulation and a control group receiving routine neonatal care. The intervention will be initiated within the first week of life and continued for a specified duration with regular monitoring of vital signs. Outcomes will be assessed using neurological motor and growth parameters. The study is expected to demonstrate that early developmental stimulation is a safe feasible and effective method to enhance neurodevelopmental outcomes in late preterm infants.

 
Close